Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study
Daniel Q. Huang(National University of Singapore), Rohit Loomba(University of California San Diego), Daniela Allende(Cleveland Clinic), Oscar W. Cummings(Indiana University Hospital), David E. Kleiner(National Institutes of Health), Norah A. Terrault(University of Southern California), Samer Gawrieh(Indiana University School of Medicine), Anna Mae Diehl(Duke Medical Center), Veeral Ajmera(University of California San Diego), Lisa Garrison(Indiana University School of Medicine), Dawn Piercy, Raj Vuppalanchi(University of Pennsylvania), Theresa Cattoor(Saint Louis University), Janet Freebersyser(Saint Louis University), Ayako Suzuki(Duke Medical Center), Mustafa R. Bashir, Mariko Kopping(Duke Medical Center), Niharika Samala(Indiana University School of Medicine), Nicole Welch(Cleveland Clinic), Cynthia Behling(Johns Hopkins University), Arun J. Sanyal(Virginia Commonwealth University), Brent A. Neuschwander‐Tetri(Saint Louis University), Laura Wilson(Johns Hopkins University), Cynthia D. Guy(Duke University Health System), Naga Chalasani(Indiana University – Purdue University Indianapolis), Annette Bellar, Danielle Carpenter(The University of Queensland), Kris V. Kowdley(Liver Institute Northwest), Achashman Berihun(Liver Institute Northwest), Rahul Yerrapothu(Cleveland Clinic), Naglaa Tawadrou(Duke Medical Center), Pannapat Angkanaworakul(Saint Louis University), Theresa Dorrian(Liver Institute Northwest), Kevin Liu(Liver Institute Northwest), Breanna Gulati(Liver Institute Northwest), James Tonascia(Johns Hopkins University), Mandy Cruz(Indiana University School of Medicine), Adam Sohal(Liver Institute Northwest), Andrew Buysse(Liver Institute Northwest), J. Vuong(Liver Institute Northwest), Jaividhya Dasarathy(Cleveland Clinic), Srinivasan Dasarathy(Cleveland Clinic), S Misić(Liver Institute Northwest), Maral Amangurbanova(University of California San Diego)
Cited by 179
Related Papers
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
|Hepatology|2017|7.2k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k